# Karus Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/karus-therapeutics

- Industry: Pharmaceuticals
- Headquarters: UK
- Website: www.karustherapeutics.com
- Total disclosed funding: $11M
- Latest round: Series B (Jun 12, 2012)
- Investors on record: 5

## About

Karus Therapeutics engages in the development of best-in-class medicines to treat inflammatory disease and cancer.

## Funding rounds

- Series B, Jun 12, 2012, $11M — Sprout Group, SV Health Investors, Novo Holdings, Longview Innovation, International Biotechnology Trust

## Investors

- Sprout Group (https://capitalatlas.ai/funds/sprout-group) — Series B
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series B
- Novo Holdings — Series B
- Longview Innovation (https://capitalatlas.ai/funds/longview-innovation) — Series B
- International Biotechnology Trust — Series B